Page 32 - MSC & Exosomes in autoimmune

Cells 2019, 8, 1605 18 of 22

21. Kusuma, G.D.; Barabadi, M.; Tan, J.L.; Morton, D.A.V.; Frith, J.E.; Lim, R. To Protect and to Preserve: Novel
Preservation Strategies for Extracellular Vesicles. Front. Pharmacol. 2018, 9, 1199. [CrossRef] [PubMed]
22. Baumgart, D.C.; Carding, S.R. Inflammatory bowel disease: Cause and immunobiology. Lancet 2007, 369,
1627–1640. [CrossRef]
23. Lee, S.H.; Kwon, J.E.; Cho, M.L. Immunological pathogenesis of inflammatory bowel disease. Intest. Res.
2018, 16, 26–42. [CrossRef] [PubMed]
24. Wu, X.F.; Ouyang, Z.J.; Feng, L.L.; Chen, G.; Guo, W.J.; Shen, Y.; Wu, X.D.; Sun, Y.; Xu, Q. Suppression of
NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration
of experimental murine colitis by the natural compound fraxinellone. Toxicol. Appl. Pharmacol. 2014, 281,
146–156. [CrossRef]
25. Cao, L.; Xu, H.; Wang, G.; Liu, M.; Tian, D.; Yuan, Z. Extracellular vesicles derived from bone marrow
mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2
macrophage polarization. Int. Immunopharmacol. 2019, 72, 264–274. [CrossRef]
26. Yang, J.; Liu, X.X.; Fan, H.; Tang, Q.; Shou, Z.X.; Zuo, D.M.; Zou, Z.; Xu, M.; Chen, Q.Y.; Peng, Y.; et al.
Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental
Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis. PLoS ONE 2015, 10, e0140551.
[CrossRef]
27. Wu, H.; Fan, H.; Shou, Z.; Xu, M.; Chen, Q.; Ai, C.; Dong, Y.; Liu, Y.; Nan, Z.; Wang, Y.; et al.
Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1.
Int. Immunopharmacol. 2019, 68, 204–212. [CrossRef]
28. Mao, F.; Wu, Y.; Tang, X.; Kang, J.; Zhang, B.; Yan, Y.; Qian, H.; Zhang, X.; Xu, W. Exosomes Derived
from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in Mice.
Biomed. Res. Int. 2017, 2017, 5356760. [CrossRef]
29. Bao, C.; Wang, B.; Yang, F.; Chen, L. Blockade of Interleukin-7 Receptor Shapes Macrophage Alternative
Activation and Promotes Functional Recovery after Spinal Cord Injury. Neuroscience 2018, 371, 518–527.
[CrossRef]
30. Katz, G.; Pobezinsky, L.A.; Jeurling, S.; Shinzawa, M.; Van Laethem, F.; Singer, A. T cell receptor stimulation
impairs IL-7 receptor signaling by inducing expression of the microRNA miR-17 to target Janus kinase 1.
Sci. Signal 2014, 7, ra83. [CrossRef]
31. Park, K.S.; Bandeira, E.; Shelke, G.V.; Lässer, C.; Lötvall, J. Enhancement of therapeutic potential of
mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res. Ther. 2019, 10, 288. [CrossRef] [PubMed]
32. Gazdic, M.; Simovic Markovic, B.; Vucicevic, L.; Nikolic, T.; Djonov, V.; Arsenijevic, N.; Trajkovic, V.;
Lukic, M.L.; Volarevic, V. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity
of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent
manner. J. Tissue Eng. Regen. Med. 2018, 12, e1173–e1185. [CrossRef] [PubMed]
33. Gazdic, M.; Markovic, B.S.; Arsenijevic, A.; Jovicic, N.; Acovic, A.; Harrell, C.R.; Fellabaum, C.; Djonov, V.;
Arsenijevic, N.; Lukic, M.L.; et al. Crosstalk between mesenchymal stem cells and T regulatory cells is
crucially important for the attenuation of acute liver injury. Liver Transpl. 2018, 24, 687–702. [CrossRef]
34. Milosavljevic, N.; Gazdic, M.; Simovic Markovic, B.; Arsenijevic, A.; Nurkovic, J.; Dolicanin, Z.; Djonov, V.;
Lukic, M.L.; Volarevic, V. Mesenchymal stem cells attenuate acute liver injury by altering ratio between
interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017, 23, 1040–1050. [CrossRef]
35. Milosavljevic, N.; Gazdic, M.; Simovic Markovic, B.; Arsenijevic, A.; Nurkovic, J.; Dolicanin, Z.; Jovicic, N.;
Jeftic, I.; Djonov, V.; Arsenijevic, N.; et al. Mesenchymal stem cells attenuate liver fibrosis by suppressing
Th17 cells—An experimental study. Transpl. Int. 2018, 31, 102–115. [CrossRef]
36. Gazdic, M.; Arsenijevic, A.; Markovic, B.S.; Volarevic, A.; Dimova, I.; Djonov, V.; Arsenijevic, N.; Stojkovic, M.;
Volarevic, V. Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases. Int. J. Biol. Sci. 2017, 13,
1109–1117. [CrossRef]
37. Volarevic, V.; Gazdic, M.; Simovic Markovic, B.; Jovicic, N.; Djonov, V.; Arsenijevic, N. Mesenchymal stem
cell-derived factors: Immuno-modulatory effects and therapeutic potential. Biofactors 2017, 43, 633–644.
[CrossRef]
38. Chen, L.; Xiang, B.; Wang, X.; Xiang, C. Exosomes derived from human menstrual blood-derived stem cells
alleviate fulminant hepatic failure. Stem Cell Res. Ther. 2017, 8, 9. [CrossRef]